These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 16470534)

  • 61. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.
    Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
    Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome.
    Tavil B; Cetin M; Tuncer M
    Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
    Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.
    Shen SW; Dolnikov A; Passioura T; Millington M; Wotherspoon S; Rice A; MacKenzie KL; Symonds G
    Exp Hematol; 2004 Sep; 32(9):852-60. PubMed ID: 15345287
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Age and stress related phenotypical changes in bone marrow CD34+ cells.
    Taraldsrud E; Grøgaard HK; Solheim S; Lunde K; Fløisand Y; Arnesen H; Seljeflot I; Egeland T
    Scand J Clin Lab Invest; 2009; 69(1):79-84. PubMed ID: 18836945
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Clonogenic cells of acute leukemia secondary to myeloproliferative and myelodysplastic syndromes].
    Almeida J; del Cañizo MC; Galende J; Vidriales B; Nieto MJ; Hernández MD; Rodríguez MJ; San Miguel JF
    Sangre (Barc); 1994 Oct; 39(5):331-5. PubMed ID: 7754436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
    Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
    Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.
    Josefsen D; Forfang L; Dyrhaug M; Blystad AK; Stokke T; Smeland EB; Kvalheim G
    Eur J Haematol; 2011 Dec; 87(6):494-502. PubMed ID: 21752097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
    Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
    Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.